149 related articles for article (PubMed ID: 17372243)
1. Ovarian cancer risk and polymorphisms involved in estrogen catabolism.
Holt SK; Rossing MA; Malone KE; Schwartz SM; Weiss NS; Chen C
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):481-9. PubMed ID: 17372243
[TBL] [Abstract][Full Text] [Related]
2. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
[TBL] [Abstract][Full Text] [Related]
3. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
4. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer.
Doherty JA; Weiss NS; Freeman RJ; Dightman DA; Thornton PJ; Houck JR; Voigt LF; Rossing MA; Schwartz SM; Chen C
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):357-66. PubMed ID: 15734958
[TBL] [Abstract][Full Text] [Related]
5. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.
Wang Q; Li H; Tao P; Wang YP; Yuan P; Yang CX; Li JY; Yang F; Lee H; Huang Y
DNA Cell Biol; 2011 Aug; 30(8):585-95. PubMed ID: 21438753
[TBL] [Abstract][Full Text] [Related]
6. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.
Bailey LR; Roodi N; Dupont WD; Parl FF
Cancer Res; 1998 Nov; 58(22):5038-41. PubMed ID: 9823305
[TBL] [Abstract][Full Text] [Related]
7. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
[TBL] [Abstract][Full Text] [Related]
8. Catechol-O-methyltransferase and cytochrome P-450 1B1 polymorphisms and endometrial cancer risk: a meta-analysis.
Teng Y; He C; Zuo X; Li X
Int J Gynecol Cancer; 2013 Mar; 23(3):422-30. PubMed ID: 23370603
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.
Diergaarde B; Potter JD; Jupe ER; Manjeshwar S; Shimasaki CD; Pugh TW; Defreese DC; Gramling BA; Evans I; White E
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1751-9. PubMed ID: 18628428
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk.
Reding KW; Weiss NS; Chen C; Li CI; Carlson CS; Wilkerson HW; Farin FM; Thummel KE; Daling JR; Malone KE
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1461-7. PubMed ID: 19383894
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of the estrogen-metabolizing genes CYP17 and catechol-O-methyltransferase and risk of epithelial ovarian cancer.
Garner EI; Stokes EE; Berkowitz RS; Mok SC; Cramer DW
Cancer Res; 2002 Jun; 62(11):3058-62. PubMed ID: 12036914
[TBL] [Abstract][Full Text] [Related]
12. African American-preponderant single nucleotide polymorphisms (SNPs) and risk of breast cancer.
Kato I; Cichon M; Yee CL; Land S; Korczak JF
Cancer Epidemiol; 2009 Jul; 33(1):24-30. PubMed ID: 19679043
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk.
Nock NL; Cicek MS; Li L; Liu X; Rybicki BA; Moreira A; Plummer SJ; Casey G; Witte JS
Carcinogenesis; 2006 Sep; 27(9):1842-8. PubMed ID: 16569655
[TBL] [Abstract][Full Text] [Related]
15. Association of CYP1B1 polymorphisms and breast cancer risk.
De Vivo I; Hankinson SE; Li L; Colditz GA; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):489-92. PubMed ID: 12010864
[TBL] [Abstract][Full Text] [Related]
16. Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism.
Starr JR; Chen C; Doody DR; Hsu L; Ricks S; Weiss NS; Schwartz SM
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2183-90. PubMed ID: 16172230
[TBL] [Abstract][Full Text] [Related]
17. The Val432Leu polymorphism of the CYP1B1 gene is associated with differences in estrogen metabolism and bone density.
Napoli N; Rini GB; Serber D; Giri T; Yarramaneni J; Bucchieri S; Camarda L; Di Fede G; Camarda MR; Jain S; Mumm S; Armamento-Villareal R
Bone; 2009 Mar; 44(3):442-8. PubMed ID: 18977467
[TBL] [Abstract][Full Text] [Related]
18. Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study.
Cote ML; Wenzlaff AS; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Lung Cancer; 2007 Mar; 55(3):255-62. PubMed ID: 17174438
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women.
Ghisari M; Eiberg H; Long M; Bonefeld-Jørgensen EC
Environ Health; 2014 Mar; 13(1):19. PubMed ID: 24629213
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis.
Wen W; Cai Q; Shu XO; Cheng JR; Parl F; Pierce L; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):329-35. PubMed ID: 15734954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
